In order to curb increasing youth electronic cigarette (e-cig) use, the United States Food and Drug Administration (FDA) banned the sale of flavored cartridge/pod-based products in February 2020. This mixed-methods study aimed to evaluate the impact of the FDA ban on adult JUUL users. The samples of current adult JUUL users were surveyed via Amazon Mechanical Turk at three time-points = 76 (Sample 1); = 128 (Sample 2); = 86 (Sample 3) before and after the FDA flavored/pod ban. The participants were asked to report the JUUL flavored pod used most often and answer questions on purchasing generic pods or refilling (Quantitative). JUUL users were then interviewed in order to explore their perceptions and behaviors related to the FDA ban of flavored cartridge/pod-based products (Qualitative; = 16). Quantitative data analysis evaluated the differences in variables by time-point. Qualitative data were coded into themes while using the constant comparative method. We found a significant decrease in the use of mint pods (43.4%, 22.7%, 16.3%) ( < 0.01), while there was a significant increase in the use of menthol pods (6.6%, 26.6%, 37.2%) ( < 0.01). Themes that emerged from the qualitative data included switching from mint to menthol pods, refilling pods, and switching to other products that are available in the desired flavors, such as generic pods or disposable e-cigs. Future research is needed in order to evaluate the impact of these behaviors on public health.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795757 | PMC |
http://dx.doi.org/10.3390/ijerph18010207 | DOI Listing |
Midwifery
November 2024
Department of Midwifery, University College of Northern Denmark, Selma Lagerløfsvej 2 9200 Aalborg Ø, Denmark; Graduate School of Health, Aarhus University, Jens Baggesens Vej 53, bld. 5220, DK-8200 Aarhus; Department of Occupational Health, Aarhus University Hospital, Palle Juul Jensens Boulevard 35 8200 Aarhus, Denmark; Department of Clinical Medicine, Aarhus University Hospital, Palle Juul Jensens Boulevard 82 8200 Aarhus N, Denmark. Electronic address:
Objective: Decision-making is important in user-involved maternity care and patient experience instruments Mothers Autonomy in Decision Making scale (MADM) and Mothers on Respect index (MORi) are used internationally to measure the user involvement quality and users' experiences of autonomy and respect. This study aimed to translate and qualitatively adapt the original MADM and MORi instruments to the Danish language and culture.
Methods: A forward and backward translation using a standard guideline.
J Intern Med
January 2025
Department of Nephrology and Endocrinology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Med Clin North Am
January 2025
Department of Clinical Medicine, Research Center for Emergency Medicine, Aarhus University Hospital and Aarhus University, Palle Juul-Jensens Boulevard 99, Aarhus N 8200, Denmark; Emergency Department, Horsens Regional Hospital, Denmark. Electronic address:
Proficiency in basic lung ultrasound is highly recommended for clinicians in general and internal medicine. This article will review and provide guidance for novice users on how to use lung ultrasound in clinical practice, through a pathology-oriented approach. The authors recommend a 12-zone protocol and describe how to perform and apply it in clinical practice while examining patients with clinical suspicion for the following diseases: pleural effusion, heart failure, pneumonia (bacterial and viral), interstitial lung disease, and pneumothorax.
View Article and Find Full Text PDFBioinformatics
November 2024
Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 99, Aarhus N, Midtjylland, 8200, Denmark.
Eur Heart J Qual Care Clin Outcomes
November 2024
Department of Behavioral Medicine, Faculty of Medicine, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway.
Aims: Proprotein convertase subtilisin/kexin type 9 monoclonal antibodies (PCSK9 mAbs) are recommended for high-risk patients if the low-density lipoprotein cholesterol (LDL-C) targets are not achieved with statins and ezetimibe. We studied persistence and adherence to 1) PCSK9 mAbs and 2) statins and ezetimibe in a nationwide cohort of incident PCSK9 mAb users.
Methods And Results: Information on all PCSK9 mAb users ≤80 years from 2015 through 2023 were extracted from the Norwegian Drug Registry.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!